Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrin alphaIIbbeta3 and its antagonism.

Martin J Quinn1, Tatiana V Byzova, Jun Qin

  • 1Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology/NB50, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, Ohio 44195, USA.

Arteriosclerosis, Thrombosis, and Vascular Biology
|March 15, 2003
PubMed
Summary

AlphaIIbbeta3, a key platelet protein, plays a role in blood clot formation. While IV antagonists are effective antithrombotics, oral versions and broader use in acute coronary syndromes show limitations, prompting further research into their mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kindlin-2 Deletion in Mural Cells Leads to Vascular Instability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

Kindlin-3 phosphorylation is crucial for thrombosis and hemostasis <i>in vivo</i>.

Research and practice in thrombosis and haemostasis·2025
Same author

Role of Kindlin 2 in prostate cancer.

Scientific reports·2024
Same author

Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.

Matrix biology : journal of the International Society for Matrix Biology·2023
Same author

Parkin ubiquitination of Kindlin-2 enables mitochondria-associated metastasis suppression.

The Journal of biological chemistry·2023
Same author

A mechanism of platelet integrin αIIbβ3 outside-in signaling through a novel integrin αIIb subunit-filamin-actin linkage.

Blood·2023

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • AlphaIIbbeta3 is a critical platelet integrin receptor involved in aggregation and thrombus formation.
  • Structural insights reveal how alphaIIbbeta3 signals from its cytoplasmic tail to its extracellular domain.

Purpose of the Study:

  • To explore the mechanisms of alphaIIbbeta3 antagonists in antithrombotic therapy.
  • To understand the salutary and potentially deleterious effects of alphaIIbbeta3 inhibition.

Main Methods:

  • Review of recent structural analyses of alphaIIbbeta3.
  • Analysis of clinical trial data for intravenous and oral alphaIIbbeta3 antagonists.

Main Results:

  • Intravenous alphaIIbbeta3 antagonists show significant mortality benefits in percutaneous coronary interventions.

Related Experiment Videos

  • Oral antagonists faced setbacks due to excess mortality, and broader application in acute coronary syndromes yielded mixed results.

    • Conclusions:

    • Understanding antagonist interactions with alphaIIbbeta3, informed by structural data, is crucial for explaining therapeutic efficacy and adverse events.
    • Further research is needed to optimize alphaIIbbeta3-targeted antithrombotic strategies.